Clinical professionals from across the West Midlands region have converged at Aston Villa Football Club to look at innovative ways in preventing/managing diabetes and cardiovascular disease (CVD).
Local commissioners, GPs, hospital clinicians, nurses and pharmacists were just some of the professionals who attended the West Midlands CVD and Diabetes Event – ‘Innovation, Adoption, Dissemination’ - on 10 May. The event was part of a programme under the long term conditions umbrella of the West Midlands Academic Health Science Network (WMAHSN).
The day focused on topics such as CVD challenges, atrial fibrillation (AF) - a heart condition which causes an irregular and often abnormally fast heart rate - high blood pressure, the way forward for diabetes care and improving outcomes for patients with diabetes.
The aim of the event was to enable delegates to share new ideas in tackling diabetes, atrial fibrillation and CVD, as well as showcasing innovation from around the region.
Reflecting on the event, Karen Morrey, Atrial Fibrillation Programme Lead at WMAHSN, said: “The day showed us that there is some great work going on in the West Midlands. The aim of our project is to bring these strands together to help clinicians improve outcomes for patients with AF in a cost effective way. We look forward to working with teams across the region to do this.”
Professor Gregory Lip, Professor of Cardiovascular Medicine at University of Birmingham, was one of the high-profile speakers at the event. He added: “Stroke prevention is the top priority in the management of patients with atrial fibrillation. We need simple steps in streamlining the decision-making pathway for managing such patients that can be the bridge from primary to hospital care management.”